VIVENK
Live / Registered — Registered (as of 09 Apr 2024)
What this means for you
Registered since 09 Apr 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 09 Apr 2030: the §71 affidavit of use).
Record
- Serial number
- 79300658
- Registration number
- 7349251
- Mark type
- Word mark
- Filed
- 27 Nov 2020
- Published for opposition
- 23 Jan 2024
- Registered
- 09 Apr 2024
- Next maintenance filing
- §71 affidavit of use, due by 09 Apr 2030 (grace period to 09 Oct 2030)
- Attorney of record
- MICHAEL M. MORRIS
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products and preparations containing natural killer cells for the treatment of cancer; medical cell products for the treatment of cancer in the nature of natural killer cells for use in immuno-oncology
Owner
Board proceedings on this mark
- Ex Parte Appeal No. 79300658 — Glycostem Therapeutics B.V., filed 14 Jun 2022 (Terminated)
The owner also pleads this mark in 1 other Board proceeding.
Prosecution history
- 09 Jul 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 17 Jan 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 30 Dec 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 30 Dec 2024 — FINAL DISPOSITION PROCESSED
- 19 Oct 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 09 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 09 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Jan 2024 — PUBLISHED FOR OPPOSITION
- 22 Jan 2024 — NOTIFICATION PROCESSED BY IB
- 03 Jan 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 03 Jan 2024 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 03 Jan 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Dec 2023 — EXPARTE APPEAL TERMINATED
- 18 Dec 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER